Exact Mass: 288.02230480000003
Exact Mass Matches: 288.02230480000003
Found 98 metabolites which its exact mass value is equals to given mass value 288.02230480000003,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
3-deoxy-D-arabino-heptulosonate-7-phosphate
2-dehydro-3-deoxy-d-arabino-heptonate 7-phosphate, also known as 2-dahp or 3-deoxy-arabino-heptulonic acid 7-phosphoric acid, is a member of the class of compounds known as monosaccharide phosphates. Monosaccharide phosphates are monosaccharides comprising a phosphated group linked to the carbohydrate unit. 2-dehydro-3-deoxy-d-arabino-heptonate 7-phosphate is soluble (in water) and a moderately acidic compound (based on its pKa). 2-dehydro-3-deoxy-d-arabino-heptonate 7-phosphate can be found in a number of food items such as prairie turnip, horned melon, bilberry, and biscuit, which makes 2-dehydro-3-deoxy-d-arabino-heptonate 7-phosphate a potential biomarker for the consumption of these food products. 2-dehydro-3-deoxy-d-arabino-heptonate 7-phosphate exists in E.coli (prokaryote) and yeast (eukaryote).
5'-(3',4'-Dihydroxyphenyl)-gamma-valerolactone sulfate
5-(3,4-dihydroxyphenyl)-gamma-valerolactone sulfate is a cocoa metabolite from gut microflora. It is found in urine.
5-(3',4'-Dihydroxyphenyl)-γ-valerolactone 4'-sulfate
5-(3',5'-Dihydroxyphenyl)-γ-valerolactone sulfate
Ciprofibrate
C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent > C98150 - Fibrate Antilipidemic Agent C - Cardiovascular system > C10 - Lipid modifying agents > C10A - Lipid modifying agents, plain > C10AB - Fibrates D009676 - Noxae > D002273 - Carcinogens > D020025 - Peroxisome Proliferators D057847 - Lipid Regulating Agents > D000960 - Hypolipidemic Agents D009676 - Noxae > D000963 - Antimetabolites Ciprofibrate (Win35833) is a potent peroxisome proliferator and increases the phosphorylation level of the PPARalpha[1]. Ciprofibrate acts as an orally active hypolipidaemic agent and can be used for the research of primary hyperlipidaemias[2].
Ciprofibrate
C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent > C98150 - Fibrate Antilipidemic Agent C - Cardiovascular system > C10 - Lipid modifying agents > C10A - Lipid modifying agents, plain > C10AB - Fibrates D009676 - Noxae > D002273 - Carcinogens > D020025 - Peroxisome Proliferators D057847 - Lipid Regulating Agents > D000960 - Hypolipidemic Agents D009676 - Noxae > D000963 - Antimetabolites CONFIDENCE standard compound; INTERNAL_ID 691; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4943; ORIGINAL_PRECURSOR_SCAN_NO 4941 CONFIDENCE standard compound; INTERNAL_ID 691; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4958; ORIGINAL_PRECURSOR_SCAN_NO 4954 CONFIDENCE standard compound; INTERNAL_ID 691; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4923; ORIGINAL_PRECURSOR_SCAN_NO 4921 CONFIDENCE standard compound; INTERNAL_ID 691; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4952; ORIGINAL_PRECURSOR_SCAN_NO 4949 ORIGINAL_ACQUISITION_NO 4951; CONFIDENCE standard compound; INTERNAL_ID 691; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_PRECURSOR_SCAN_NO 4949 CONFIDENCE standard compound; INTERNAL_ID 691; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4951; ORIGINAL_PRECURSOR_SCAN_NO 4949 CONFIDENCE standard compound; INTERNAL_ID 691; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4945; ORIGINAL_PRECURSOR_SCAN_NO 4943 Ciprofibrate (Win35833) is a potent peroxisome proliferator and increases the phosphorylation level of the PPARalpha[1]. Ciprofibrate acts as an orally active hypolipidaemic agent and can be used for the research of primary hyperlipidaemias[2].
4,10-Dihydroxy-6-methylfuro[3,4:6,7]naphtho[2,3-d]-1,3-dioxole-5,9-dione
2-acetoxymethyl-5--bithienyl(2,5)|5-Acetoxymethyl-2--dithienyl-(5,2)|5-acetoxymethyl-5-(3-butene-1-ynyl)-2,2-bithiophene|5-(3-Buten-1-ynyl)-2,2-bithienyl-5-methylacetate|5-Acetoxymethyl-5-but-3-en-1-inyl-<2,2>-bithienyl|5-acetoxymethyl-5-but-3-en-1-ynyl-[2,2]bithiophenyl
7,8-dihydroxy-3-(3-hydroxy-4-oxo-4H-pyran-2-yl)-2H-chromen-2-one
5-(3,4-Dihydroxyphenyl)-gamma-valerolactone sulfate
(5-(but-3-en-1-yn-1-yl)-[2,2-bithiophen]-5-yl)methyl acetate
4(1H)-Quinazolinone,3-(4-chlorophenyl)-2,3-dihydro-2-thioxo-
4-(4-CHLORO-PHENYL)-5-PYRIDIN-4-YL-4H-[1,2,4]TRIAZOLE-3-THIOL
5-chloro-3-[[ethoxy(methyl)phosphoryl]methyl]-1-benzothiophene
C12H14ClO2PS (288.01406240000006)
phenyl N-[4-(trifluoromethyl)-1,3-thiazol-2-yl]carbamate
3,5-BIS(TRIFLUOROMETHYL)MANDELIC ACID
C10H6F6O3 (288.02211179999995)
3-((4-CHLOROPHENYL)SULFONYL)-4-ETHOXYBUT-3-EN-2-ONE
C12H13ClO4S (288.02230480000003)
2,6-diamino-4-(4-chlorophenyl)-4H-thiopyran-3,5-dicarbonitrile
4-(1,1,1,3,3,3-Hexafluoro-2-hydroxypropan-2-yl)benzoic acid
C10H6F6O3 (288.02211179999995)
3-CHLORO-4-([5-(TRIFLUOROMETHYL)-2-PYRIDINYL]OXY)ANILINE
C12H8ClF3N2O (288.02772239999996)
Thiazolidine, 3-(methylsulfonyl)-2-(3-nitrophenyl)- (9CI)
Thiazolidine, 3-(methylsulfonyl)-2-(4-nitrophenyl)- (9CI)
2-Methoxy-4,6-bis(trifluoromethyl)benzoic acid
C10H6F6O3 (288.02211179999995)
4(1H)-Quinazolinone,3-(3-chlorophenyl)-2,3-dihydro-2-thioxo-
2,6-diamino-4-(2-chlorophenyl)-4H-thiopyran-3,5-dicarbonitrile
5-bromo-2-(tert-butyldimethylsilyloxy)pyrimidine
C10H17BrN2OSi (288.02934519999997)
3-[6-(2-Chlorophenyl)-2-pyridinyl]-1,2,4-thiadiazol-5-amine
3-[6-(3-Chlorophenyl)-2-pyridinyl]-1,2,4-thiadiazol-5-amine
3-[6-(4-Chlorophenyl)-2-pyridinyl]-1,2,4-thiadiazol-5-amine
Dimethyl 2-(5-chloro-3-nitropyridin-2-yl)malonate
C10H9ClN2O6 (288.01491239999996)
3-(2-CHLORO-PHENYL)-2-MERCAPTO-3H-QUINAZOLIN-4-ONE
1-(4-Chloro-2-(3-methyl-1H-pyrazol-1-yl)phenyl)-2,2,2-trifluoroethanone
C12H8ClF3N2O (288.02772239999996)
Ethyl 2-{[(trifluoromethyl)sulfonyl]oxy}cyclopent-1-ene-1-carboxylate
4-(1,1,2,3,3,3-Hexafluoropropoxy)benzoic acid
C10H6F6O3 (288.02211179999995)
Sodium glycerol 2-phosphate tetrahydrate
C3H15Na2O10P (288.01982200000003)
[5-(5-But-3-en-1-ynylthiophen-2-yl)thiophen-2-yl]methyl acetate
D-Sedoheptulose 7-phosphate
COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
1-Carboxy-2-deoxy-alpha-D-glucopyranose 6-phosphoric acid
5-(3,5-Dihydroxyphenyl)-gamma-valerolactone sulfate
[4-[(Z)-2-hydroxy-3-oxobut-1-enyl]-2-methoxyphenyl] hydrogen sulate
[4-(3-Acetyloxiran-2-yl)-2-methoxyphenyl] hydrogen sulate
(2xi)-3-deoxy-7-O-phospho-beta-D-threo-hept-6-ulopyranosonic acid
[4-[(E)-4-hydroxy-3-oxobut-1-enyl]-2-methoxyphenyl] hydrogen sulfate
3-deoxy-D-arabino-heptulosonate-7-phosphate
A ketoaldonic acid phosphate consisting of 2-dehydro-3-deoxy-D-arabino-heptonic acid having a phospho group at the 7-position.
D-glycero-beta-D-manno-heptose 1-phosphate(2-)
D-glycero-D-manno-heptose 1-phosphate(2-) with beta-configuration at the anomeric carbon atom.
sedoheptulose 7-phosphate(2-)
An organophosphate oxoanion that is the dianion of sedoheptulose 7-phosphate arising from deprotonation of both OH groups from the phosphate.
D-glycero-alpha-D-manno-heptose 1-phosphate(2-)
D-glycero-D-manno-heptose 1-phosphate(2-) with alpha-configuration at the anomeric carbon atom.
D-glycero-D-manno-heptose 7-phosphate(2-)
The dianion obtained by removal of two protons from the phosphate group of D-glycero-D-manno-heptose 7-phosphate.
2-Hydroxy-5-[(5-oxooxolan-2-yl)methyl]phenyl hydrogen sulfate
D-glycero-D-manno-heptose 1-phosphate(2-)
Dianion of D-glycero-D-manno-heptose 1-phosphate arising from deprotonation of both phosphate OH groups.
5-(3,4-dihydroxyphenyl)-gamma-valerolactone 3-O-sulfate
A butan-4-olide that is gamma-valerolactone in which one of the methyl hydrogens has been replaced by a 3-sulfooxy-4-hydroxyphenyl group.
D-glycero-alpha-D-manno-heptose 7-phosphate(2-)
The dianion obtained by removal of two protons from the phosphate group of D-glycero-alpha-D-manno-heptose 7-phosphate.
D-glycero-beta-D-manno-heptose 7-phosphate(2-)
The dianion obtained by removal of two protons from the phosphate group of D-glycero-beta-D-manno-heptose 7-phosphate.
[5'-(but-3-en-1-yn-1-yl)-[2,2'-bithiophen]-5-yl]methyl acetate
(3e)-4-(2,6-dichloro-3,5-dimethoxyphenyl)pent-3-en-2-one
{2-methoxy-4-[(1e)-3-methoxy-3-oxoprop-1-en-1-yl]phenyl}oxidanesulfonic acid
5-(3-buten-1-ynyl)-2,2'-bithienyl-5'-methylacetate
{"Ingredient_id": "HBIN011008","Ingredient_name": "5-(3-buten-1-ynyl)-2,2'-bithienyl-5'-methylacetate","Alias": "NA","Ingredient_formula": "C15H12O2S2","Ingredient_Smile": "CC(=O)OCC1=CC=C(S1)C2=CC=C(S2)C#CC=C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "30691","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
5-(3-buten-1-ynyl)-2,2'-bithienyl-5’-methyl-acetate
{"Ingredient_id": "HBIN011009","Ingredient_name": "5-(3-buten-1-ynyl)-2,2'-bithienyl-5\u2019-methyl-acetate","Alias": "NA","Ingredient_formula": "C15H12O2S2","Ingredient_Smile": "CC(=O)OCC1=CC=C(S1)C2=CC=C(S2)C#CC=C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT14526","TCMID_id": "2784","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}